These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1591725

  • 1. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1.
    Basu A, Lazo JS.
    Cancer Res; 1992 Jun 01; 52(11):3119-24. PubMed ID: 1591725
    [Abstract] [Full Text] [Related]

  • 2. Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.
    Basu A, Kozikowski AP, Sato K, Lazo JS.
    Cancer Res; 1991 May 15; 51(10):2511-4. PubMed ID: 2021930
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the protein kinase C signal transduction pathway in cisplatin-sensitive and -resistant human small cell lung carcinoma cells.
    Basu A, Weixel K, Saijo N.
    Cell Growth Differ; 1996 Nov 15; 7(11):1507-12. PubMed ID: 8930400
    [Abstract] [Full Text] [Related]

  • 4. Enhancement of cisplatin sensitivity of cisplatin-resistant human cervical carcinoma cells by bryostatin 1.
    Mohanty S, Huang J, Basu A.
    Clin Cancer Res; 2005 Sep 15; 11(18):6730-7. PubMed ID: 16166454
    [Abstract] [Full Text] [Related]

  • 5. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM, Heikkilä J, Akerlind G, Pettit GR, Akerman KE.
    Cancer Res; 1990 Jun 01; 50(11):3422-8. PubMed ID: 2334938
    [Abstract] [Full Text] [Related]

  • 6. Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells.
    Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE.
    Clin Cancer Res; 1995 Dec 01; 1(12):1581-7. PubMed ID: 9815959
    [Abstract] [Full Text] [Related]

  • 7. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity.
    Levine BL, May WS, Tyler PG, Hess AD.
    J Immunol; 1991 Nov 15; 147(10):3474-81. PubMed ID: 1834742
    [Abstract] [Full Text] [Related]

  • 8. Comparison of effects of bryostatins 1 and 2 and 12-O-tetradecanoylphorbol-13-acetate on protein kinase C activity in A549 human lung carcinoma cells.
    Dale IL, Bradshaw TD, Gescher A, Pettit GR.
    Cancer Res; 1989 Jun 15; 49(12):3242-5. PubMed ID: 2720677
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines.
    Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, Davidson NE.
    Cancer Res; 1992 Mar 01; 52(5):1278-83. PubMed ID: 1737390
    [Abstract] [Full Text] [Related]

  • 10. Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
    Szallasi Z, Denning MF, Smith CB, Dlugosz AA, Yuspa SH, Pettit GR, Blumberg PM.
    Mol Pharmacol; 1994 Nov 01; 46(5):840-50. PubMed ID: 7969070
    [Abstract] [Full Text] [Related]

  • 11. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
    Grant S, Turner AJ, Freemerman AJ, Wang Z, Kramer L, Jarvis WD.
    Exp Cell Res; 1996 Oct 10; 228(1):65-75. PubMed ID: 8892972
    [Abstract] [Full Text] [Related]

  • 12. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: dissociation of activities using 26-epi-bryostatin 1.
    Szallasi Z, Du L, Levine R, Lewin NE, Nguyen PN, Williams MD, Pettit GR, Blumberg PM.
    Cancer Res; 1996 May 01; 56(9):2105-11. PubMed ID: 8616857
    [Abstract] [Full Text] [Related]

  • 13. Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II).
    Basu A, Teicher BA, Lazo JS.
    J Biol Chem; 1990 May 25; 265(15):8451-7. PubMed ID: 2341390
    [Abstract] [Full Text] [Related]

  • 14. Synergistic action of calcium ionophore A23187 and protein kinase C activator bryostatin 1 on human B cell activation and proliferation.
    Drexler HG, Gignac SM, Pettit GR, Hoffbrand AV.
    Eur J Immunol; 1990 Jan 25; 20(1):119-27. PubMed ID: 1689659
    [Abstract] [Full Text] [Related]

  • 15. Contrasting duration of inhibition of cell-cell communication in primary mouse epidermal cells by phorbol 12,13-dibutyrate and by bryostatin 1.
    Pasti G, Rivedal E, Yuspa SH, Herald CL, Pettit GR, Blumberg PM.
    Cancer Res; 1988 Jan 15; 48(2):447-51. PubMed ID: 3422054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mimicry of bryostatin 1 induced phosphorylation patterns in HL-60 cells by high-phorbol ester concentrations.
    Warren BS, Kamano Y, Pettit GR, Blumberg PM.
    Cancer Res; 1988 Nov 01; 48(21):5984-8. PubMed ID: 3167850
    [Abstract] [Full Text] [Related]

  • 19. The role of protein kinase C isoenzymes in the growth inhibition caused by bryostatin 1 in human A549 lung and MCF-7 breast carcinoma cells.
    Stanwell C, Gescher A, Bradshaw TD, Pettit GR.
    Int J Cancer; 1994 Feb 15; 56(4):585-92. PubMed ID: 8112895
    [Abstract] [Full Text] [Related]

  • 20. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
    Dell'Aquila ML, Nguyen HT, Herald CL, Pettit GR, Blumberg PM.
    Cancer Res; 1987 Nov 15; 47(22):6006-9. PubMed ID: 3478136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.